New paper: predicting pyrazinamide resistance Philip Fowler, 20th March 202420th March 2024 This paper has finally been published and you can find it here. It had a slightly tortuous journey from original preprint to updated preprint and now publication. In brief, we use a range of structural, chemical and evolutional features to learn which missense mutations in PncA (encoded by pncA) are associated with resistance to pyrazinamide, one of the four first-line antibiotics used to treat tuberculosis. This research output is designed to be reproducible; you can retrain all machine learning models and replot (nearly) all the figures in the paper using this GitHub repository. Share this:Twitter Related antimicrobial resistance clinical microbiology publication research tuberculosis
antimicrobial resistance New publication: Validating a bespoke 96-well plate for high-throughput drug susceptibility testing of M. tuberculosis 28th August 201829th September 2018 This paper, published in Antimicrobial Agents and Chemotherapy, determines the reproducibility and accuracy of minimum… Share this:Twitter Read More
New publication: CRyPTIC Data Compendium 16th August 202216th August 2022 The large and comprehensive dataset of clinical tuberculosis isolates collected by the CRyPTIC project is… Share this:Twitter Read More
publication New Publication: Lipids can form anti-registered phases 23rd September 201629th September 2018 When we think of lipids phase separating in a cell membrane we usually think of… Share this:Twitter Read More